ScholarIQanswers from OpenAlex

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo

PaperCitations, authors & open-access status

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo have?

ScholarIQcitation count

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo has 174 citations in the OpenAlex counts ScholarIQ stores.

When was Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo published?

ScholarIQyear

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo has 2018 year in the ScholarIQ index.

What is the open-access status of Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo?

ScholarIQoa status

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo has bronze oa status in the ScholarIQ index.

What is the DOI of Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo?

ScholarIQdoi

The DOI for Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo is on the source record.

What is the PMID of Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo?

ScholarIQpmid

The PMID for Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo is on the source record.

What is the OpenAlex record for Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo?

ScholarIQopenalex

The OpenAlex for Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial